A Clinical study and Management of Cholelithiasis by Gopi, R
 “A CLINICAL STUDY AND MANAGEMENT OF 
CHOLELITHIASIS” 
Dissertation submitted to 
DR.M.G.R.MEDICAL UNIVERSITY, 
CHENNAI 
TAMIL NADU 
With partial fulfillment of the regulations for the award of the degree of 
BRANCH - I M.S(GENERAL SURGERY) 
APRIL 2019 
 
 
 
 
 
 
 
 
Government Kilpauk Medical College 
Chennai 
April -2019 
 
 
 
DECLARATION BY THE CANDIDATE 
 I hereby declare that this dissertation thesis “A CLINICAL STUDY AND 
MANAGEMENT OF CHOLELITHIASIS‖ is a bonafide and genuine research 
work carried out by me in the Department of General Surgery, Government 
Kilpauk Medical and Hospital, Chennai-10 under the guidance of our Chief  Prof. 
Dr.B. SANTHI M.S., Government Royapettah Hospital, Kilpauk Medical 
College, Chennai. 
 This dissertation is submitted to THE TAMILNADU DR. M.G.R. 
MEDICAL UNIVERSITY, CHENNAI in partial fulfillment of the University 
regulations for the award of M.S degree (General Surgery) Branch I, examination 
to be held in APRIL 2019. 
 
 
Date:        DR .R. GOPI, 
 
Place: Chennai     Signature of the Candidate 
 
 
 
BONAFIDE CERTIFICATE 
  
This is to certify that the dissertation entitled “A CLINICAL STUDY AND 
MANAGEMENT OF CHOLELITHIASIS”submitted by DR .R. GOPI ,to the 
Tamil Nadu Dr. M.G.R. Medical University Chennai inpartial fulfillment of the 
requirement for the award of M.S Degree Branch – I (General Surgery) is a 
bonafide researchwork were carried out by her under direct supervision 
&guidance. 
 
 
Prof. Dr.B.SANTHI, M.S,        Prof.Dr.V.RAMALAKSHMI,M.S, 
Department Of Gen. Surgery,     Head of the Department,         
Govt. Royapettah Hospital,  Department Of Gen. Surgery, 
Kilpauk Medical College,            Govt. Royapettah Hospital,  
Chennai-10.     Kilpauk Medical College,   
      Chennai-10. 
 
 
 
 
Prof. Dr.P.VASANTHAMANI MD, DGO, 
MNAMS, DCPSY, MBA,  
   Dean, Kilpauk Medical College and Hospital 
  Chennai-10. 
  
 
    
 
 
 
 
  
 
 
CERTIFICATE BY THE GUIDE 
This is to certify that the dissertation titled “A CLINICAL STUDY AND 
MANAGEMENT OF CHOLELITHIASIS”is a bonafide research work done by 
post graduate in M.S. General Surgery, GovernmentKilpauk Medical College& 
Hospital, Chennai-10 under my direct guidance and supervision in my satisfaction, 
in partial fulfillment of the requirements for the degree of M.S. General Surgery. 
  
Date:     
Place: Chennai   
 
 Prof. Dr. B.SANTHI, M.S., 
 Department of General Surgery, 
 Govt. Royapettah Hospital,   
 Kilpuak Medical College,   
 Chennai. 
 
 
 
 
 DECLARATION 
 
            I  Dr. R. GOPI, declare that this study on “A CLINICAL STUDY AND 
MANAGEMENT OF CHOLELITHIASIS”at the Department of Surgery, Govt. 
Royapettah Hospital during the period from Febeuary2018 to July 2018. I also 
declare that this Bonafide work a part of this work was not submitted by me or any 
others for any award, degree, diploma to any other College, University, Board 
either in India or abroad. This is submitted to The Tamilnadu Dr. M. G. R. Medical 
University, Chennai in partial fulfillment of the rules and regulations for the M.S. 
degree examination in General Surgery. 
 
 
 
Place :Chennai            Dr.R. GOPI,                                 
 Date :     
 
 
 
 
 
  
 
 
 
 
 
 PLAGIARISM CERTIFICATE 
 
 
 
This is to certify that this dissertation work titled ― A CLINICAL STUDY  
 
AND MANAGEMENT OF CHOLELITHIASIS” 
 
of the candidate DR.R. GOPI., with registration 
 
number 221611156 for the award of MS in the branch of GENERAL 
 
SURGERY. I personally verified the urkund.com website for the purpose of 
 
plagiarism check. I found that uploaded thesis file contains from introduction to 
 
conclusion pages and result shows 18 percentage of plagiarism in the 
 
dissertation. 
 
 
 
 
 
 
 
Guide & supervisor sign with seal 
 
 
 
 
 
 
 
 
 
 
 ACKNOWLEDGEMENT 
 
I express my sincere gratitude to ChiefProf.Dr. B.SANTHI, M.S., 
for her invaluable guidance and encouragement during the course of this 
study. 
    I sincerely thank Prof. Dr.V.RAMALAKSHMI, M.S., 
Professor and Head of the Department, for his valuable advices and 
support to complete this study. 
I am very grateful to the Medical Superintendent Prof. Dr.R.  
KANNAN ., M.S., for the help and guidance throughout the course. 
    I am grateful and thankful to Prof. P.VASANTHAMANI MD, DGO, 
 
MNAMS, DCPSY, MBA, our Dean, Kilpauk Medical College and Hospital for 
 
providing me with the opportunity to conduct this study in the Department of 
 
General Surgery, Government  Royapettah hospital ,Kilpauk Medical College 
& Hospital. 
 
I would like to thank the H O D and faculty members, 
Department of Anaesthesiology for their help and their guidance in 
preparing this dissertation. 
 I would also thank the H O D and faculty members, 
Department of Radiology for their cooperation and helping me 
in preparing thisstudy. 
 
 
   I am indebted to my teachers Dr.Kenny Robert M.S., 
Dr.Suganeswwaran M.S., for their keen interest andvaluable advice. 
    I also thank my colleagues for their kind support. 
    I am thankful to my patients who participated and cooperated 
with me,without whom the study was not possible. 
 LIST OF ABBREVIATIONS 
 
 
CCK - Cholecystokinin 
CBD - Common bile duct 
US - Ultrasound 
GB - Gallbladder 
 
 
IDA - Imminodiacetic acid 
 
 
ESWL - Extra corporeal shock wave lithotripsy 
MTBE - Methyl tert butyl ether 
OCP - Oral contraceptive pill 
ECG - Electro cardio gram 
LFT - Liver function test 
Lap -Laparoscopy 
OPD - Out Patient Department 
 
 
SGOT - Serum Glutamic Oxaloacetic Transaminase 
SGPT - Serum Glutamic Pyruvic Transaminase 
BT - Bleeding Time 
 
 
CT - Clotting Time 
 PT - Prothrombin Time 
SG - Stone in gallbladder 
SS - Solitary Stone in gallbladder 
MS - Multiple stone in gallbladder 
BDS - Common Bile duct stone 
CDCA - Chenodeoxycholic acid 
UDCA - Ursedeoxycholic acid 
TG -Thickening ofgallbladde 
Yrs – Years 
 
 
NS – Not significant 
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3  
 INTRODUCTION 
 
 
Among the many distinguished names in Hindu medicine is that of SUSHRUTA, 
 
The Father of Indian surger . Hecompiled the surgical knowledge of his time in his 
 
 classic ―SushrataSamhitha‖. It isbelieved that this       
 
classicwascompiledbetween800B.C.and400A.D.Hedescribedjaundiceas―pitta-  
 
ashmarijanya‖ meaning a jaundice caused by stone in bile.1It was also known that  
 
such jaundice could be caused by wrongdiet. 
 
 
6% of prevelance gall stone was found in india.Diagnosis of gallstone is  
by proper history and physical examination and combining it with 
appropriate investigations. With the help of ultrasound we can easily 
identify gall stones. 
Because of increase incident of Gall stones and its variable presentations 
in there is a need for study which can provide prevalence, clinical 
presentations and management outcomes.  
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AIMS AND OBJECTIVES 
 
 
1. To study the age and sexdistribution. 
 
 
 
2. To study the various modes ofpresentation. 
 
 
 
3. To study safety and efficacy of laparoscopic cholecystectomy in patients of 
cholelithiasis by comparing with results of open cholecystectomy by 
comparing use of post-operative pain ,use of analgesia, post-operative 
hospital stay, wound infection
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REVIEW OF LITERATURE 
HISTORICAL ASPECTS 
 
Gallstones were described before the modern era of cholecystectomy by 
Langenbuch in the late 19th century. He widened the understanding of gallstone 
pathology and performed the first successful cholecystectomy.  
 
First elective cholecystectomy was done by Bobbs in 1867. First 
successful cholecystectomy was done by Karl Langenbuch on July 15th 1882 in 
Berlin on a male patient suffering from biliary colic for years. First 
cholecystojejunostomy for CBD obstruction by Von Winiwarter in 1882 and 
First successful choledochotomy by Courvoisier in 1882. First successful 
choledochojejunostomy was done by Sprengel in 1891
[7]
. First 
hepaticoduodenostomy by W.J.Mayo in 1905.
8
 
 
First time accurate diagnosis of gallbladder disease was demonstrated by 
Graham and Cole by oral cholecystography. First PTC was done by Huard and 
Doxun in 1937. 
 
The Endoscopic Retrograde Cholengiopancreatography was first performed by 
Mecune in 1937. Mirizzi introduced operative cholangiography in 1937 in 
Argentina. First gallstones dissolution in man using CDCA was reported by 
Miyo group in 1972. Makino reported gallstones dissolution by UDCA. 
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The surgical techniques started to evolve in the late 1800, John Bobbs 
was an Indiana surgeon and others attempted to perform cholecystolithotomy, 
removing the stone from the gallbladder and leaving the organ in situ. First 
percutaneous cholecystolithotomy by Akiyama et al in 1985, Kerlan et al in 
1985.Cope et al in 1990 removed the smaller calculi by wire baskets, 
fragmentation of larger calculi may be done with electro hydraulic or laser 
mediated intracorporal lithotripsy by Burhenne et al in 1975 and Pinacus et al in 
1989.Combined surgical and radiological intervention [mini cholecystostomy] 
was described by Burhenne et al in 1985. 
In 1985, first laparoscopically.assisted cholecystectomy was performed by 
Muhe in Boblingen,  
 
Cadiere and colleagues reported the first successful clinical 
implementation of telerobotics in 1998 when they accomplished a laparoscopic 
cholecystectomy using a prototype of the  
Da Vinci robotic surgical system.
10
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EMBRYOLOGY 
 
The genesis of the extrahepatic biliary duct system and gallbladder may, perhaps, 
be the responsibility distal portion of the hepatic diverticulum. By the end of the 
4th week, it has produced the cystic gallbladder primordium. The common bile 
duct and the hepatic ducts may be seen at theweek. The solid stage of the ducts 
takes place during the 5th week. The ducts elongate to reach progressively 
forming at this time. Slow ductal recanalization occurs approximately from the 6th 
weeks. Human fetal gallbladder contractility in the second half of pregnancy has 
beenphysiological role is unknown.3 
 
 
 
 
 
Drawing of the normal embryologic development of the gallbladder and 
bile ducts illustrates the foregut (A), the cranial end of the hepatic 
diverticulum, which represents pars hepatica (B) and the cystic 
diverticulum (C). The ventral (D) and dorsal (E) pancreas are 
alsodemonstrated. 
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SURGICAL ANATOMY 
 
ANATOMY OF EXTRAHEPATIC BILIARY SYSTEM 
The gallbladder lies on the underside of the liver in the main 
 
liverscissura at the junction of the right and left lobes of the 
 
liver. The relationship of the gallbladder to the liver varies 
 
between being embedded within the liver substance to being 
 
suspended by a mesentry. It is a pear-shaped structure, 7.5– 
 
12 cm long, with a normal capacity of about 25–30 mL. The 
 
anatomical divisions are a fundus, a body and a neck that terminates 
 
in a narrow infundibulum. The muscle fibres in the 
 
wall of the gallbladder are arranged in a criss-cross manner, 
 
being particularly well developed in its neck. The mucous 
 
membrane contains indentations of the mucosa that sink into 
 
the muscle coat; these are the crypts of Luschka. 
 
 
 
The cystic duct is about 3 cm in length but the length 
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is variable. The lumen is usually 1–3 mm in diameter. The 
 
mucosa of the cystic duct is arranged in spiral folds known as 
 
the valves of Heister and the wall is surrounded by a sphincteric 
 
structure called the sphincter of Lütkens. The cystic 
 
duct joins the supraduodenal segment of the common hepatic 
 
duct in 80% of cases, however the anatomy may vary and the 
 
junction may be much lower in the retroduodenal or even 
 
retropancreatic part of the bile duct. Occasionally, the cystic 
 
duct may join the right hepatic duct or even a right hepatic 
 
sectorial duct . 
 
The common hepatic duct is usually less than 2.5 cm long 
 
and is formed by the union of the right and left hepatic ducts. 
 
The common bile duct is about 7.5 cm long and formed by the 
 
junction of the cystic and common hepatic ducts. It is divided 
into four parts: 
●● the supraduodenal portion, about 2.5 cm long, runs in the 
free edge of the lesser omentum; 
●● theretroduodenal portion; 
●● the infraduodenal portion lies in a groove, but at times in 
a tunnel, on the posterior surface of the pancreas; 
●● theintraduodenal portion passes obliquely through the 
wall of the second part of the duodenum, where it is 
surrounded by the sphincter of Oddi, and terminates by 
opening on the summit of the ampulla of Vater. 
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The cystic artery, a branch of the right hepatic artery, usually 
 
arises behind the common hepatic duct  
 
Occasionally, an accessory cystic artery arises from the gastroduodenal 
 
artery. In 15% of cases the right hepatic artery and/ 
 
or the cystic artery crosses in front of the common hepatic 
 
duct and the cystic duct. 
 
Calot‘s triangle, or the hepatobiliary triangle, was initially 
 
described by Calot as the space bordered by the cystic 
 
duct inferiorly, the common hepatic duct medially and the 
 
superior border of the cystic artery. This has been modified 
 
in contemporary literature to be the area bound superiorly by 
 
the inferior surface of the liver, laterally by the cystic duct 
 
and the medial border of the gallbladder and medially by the 
 
common hepatic duct. It is an important surgical landmark 
 
as the cystic artery usually can be found within its boundaries 
 
and should be identified by surgeons performing a cholecystectomy 
 
to avoid damage to the extrahepatic biliary system. 
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 ANATOMY OF GALL BLADDER, INFERIOR VIEW 
 
 
 
anatomy of the gallbladder, biliary radicals, 
pancreatic duct and the hepatopancreatic ampulla 
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BLOOD SUPPLY OF EXTRAHEPATIC BILIARY SYSTEM: 
The blood supply to the extrahepatic biliary tree originates (1) distally from  
gastroduodenal, retroduodenal, and posterosuperiorpancreatoduodenal 
arteries and2proximally from the right hepatic and cystic arteries. These 
arteries supply the common bile and common hepatic ducts through 
branches running parallel to the duct in the 3- and 9-o'clock positions 1. 
The extrahepatic biliary tree is vulnerable to ischemic injury. To avoid 
disrupting the fragile inconstant blood supply to the duct, it is important 
not to strip the investing areolar tissue around it during dissection and 
isolation. Ischemia of the bile duct will not be readily evident at time of 
dissection but can result in biliary stricture or leakpostoperatively. 
 
The gallbladder is supplied by a single cystic artery.. The cystic artery 
may originate from the left hepatic ,, common hepatic, gastroduodenal, or 
superiormesenteric arteries. The cystic arterymay  arises from the right 
branch of the hepatic artery, passes posterior to the common hepatic duct 
and over the cystic duct to the superior aspect of the gallbladder neck, on 
which it descends and divides into superficial and deep branches. 13,14The 
cystic artery is an end artery and its occlusion is followed by the gangrene 
of the gallbladder.3 
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VENOUS DRAINAGE: 
 
Cystic veins draining the gallbladder vary. Those from its superior surface are in 
the alveolar tissue between the gallbladder and liver, usually entering the through 
the vertical fossa.to join the hepatic veins. The remainder form one or two cystic 
veins which commonly enter the liver either directly or after joining the veins 
draining the hepatic ducts and upper bile duct. 1 Rarely a single or double cystic 
veins drain into the right portal branch.11 
 
LYMPHATIC DRAINAGE OF GALLBLADDER: Proximally the 
lymphatic channels of the gallbladder communicate with those of 
Glisson‗s capsule of the liver which in turn drain into the thoracic duct 
through several channels. 1Distally the lymphatics from gallbladder and 
extrahepatic bile duct drain into the cystic lymph node, which is situated 
near the cystic artery origin from the right hepatic artery. Efferent vessels 
from the cystic nodedrain into the nodes along the free border of 
hepatoduodenal,ligament and to the superior pancreatic duodenal nodes 
inferiorly and hilar lymph nodes superiorly. All these in turn drain into 
celiac lymph nodes. 
 
INNERVATION:Parasy.mpathetic (vagal) 
Preganglionic sympathetics and visceral afferent fibers for pain reach the 
celiac plexus by way of the greater thoracic splanchnic nerves. 
Fibers from the right phrenic nerve travel by way of the phrenic, celiac, 
and hepatic plexuses to reach the gallbladder. Many of these fibers are 
afferent and may account for the pain referred to the right hypochondrium 
and radiating to the back between the shoulder blades in some patients 
with gallbladder diseases.11 
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COMMON ANOMALIES AND VARIATIONS 
 
 
 
1. Absent gallbladder – extremely rare, autopsy incidence of 0.03% 
have been reported . 
 
2. Variation in size and shape ofgallbladder. 
 Bilobedgallbladder. 
 Funduldivertculum. 
 Phrygian cap. 
 Hour glassgallbladder 
 
3. Variation inposition 
 Left sided gallbladder, floatinggallbladder. 11a 
 
4.  Double gallbladder, duplication of gallbladder with two separate 
cavities and two separate cystic ducts has an incidence of 
approximately 1 in 4000. , Pathological process such as cholelithiasis 
and cholecystitis may involve one organ while the other isspared. 
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Blood supply to the common bile duct and common hepatic duct is illustrated: a, right 
hepatic artery; b, 9 o'clock artery ; c, retroduodenal artery; d, left hepatic artery; e, proper 
hepatic artery; f, 3 o‗clock artery; g, common hepatic artery; h, gastroduodenal artery. 7  
 
 
 
The plate system is illustrated, including the cystic plate between the gallbladder and 
the liver (A) , the hilar plate at the biliary confluence at the base of segment IV (B) , 
and the umbilical plate above the umbilical portion of the portal vein ( C ). The 
arrows show the plane of dissection of the cystic plate for cholecystectomy and the 
hilar plate for exposure of the hepatic duct confluence and the main left hepatic duct. 
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Variation of the cystic ducts. A. Low junction between cystic duct and common 
hepatic duct. B. Cystic duct adherent to the common hepatic duct. C. High junction 
between cystic duct and common hepatic duct. D. cystic duct drains into the right 
hepatic duct. E. Cystic duct that joins the common hepatic duct. F. Absence of cystic 
duct. G. Cystic duct crosses anterior to the common hepatic duct and joins it 
posteriorly. H. Cystic duct courses posteriorly to common hepatic duct and joins it 
anteriorly.13 
 
 
Anomalies of the gallbladder. A. Double gallbladder with single cystic duct. B. 
Bilobed gallbladder. C. Intrahepatic gallbladder. D. Left sidedgallbladder. 1
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Normal and variant biliary ducts. A, Normal biliary tree. B, Trifurcation of biliary 
duct (arrow). C, Right dorsocaudal branch (arrow) draining into left hepatic duct. D, 
Aberrant right hepatic duct (arrow) emptying into common hepatic duct. E, Aberrant 
right hepatic duct (arrow) draining into cystic duct 12. 
 
TRIANGLE OF CHOLECYSTECTOMY 
Calots defined a triangle of anatomical area formed by the common 
hepatic duct medially, the cystic duct laterally and the cystic artery 
superiorly11. The present concept of the triangle of cholecystectomy has for 
its upper limit not the cystic artery.but the inferior surface of the liver. 21 
This triangle is of surgical importance because a number of important 
structures pass through it.Therefore during cholecystectomy there is a 
need to identify all structure within the triangle to prevent complications. 22 
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VARIATIONS IN ARTERIAL ANATOMY 
The cystic artery supplies the cystic . duct with one or more small arterial 
branches which have been referred to as Calot‗s arteries by Hugh and 
Kelly. These branches may be a source of troublesome bleeding during 
cholecystectomy.21,22 Anatomical variations of the hepatic and cystic arteries 
are recognized in approximately 50% of individuals. 23,24Benson and Page has 
defined 3 surgically significant variations in arterial anatomy. 
1. Accessory on double cystic artery – seen in approximately 15%to20%11 
2. Caterpillar hump of right hepatic artery seen in 5% to 15% of 
individuals.. This is the most dangerous anomaly, the tortuosity is 
known as the caterpillar turn or Moynihan‗s hump. 25 
3. Cystic artery may lies ventral to common hepatic or common bile 
duct.  
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The main variations of the cystic artery: typical course (a); double cystic artery (b); 
cystic artery crossing anterior to main bile duct (c); cystic artery originating from the 
right branch of the hepatic artery and crossing the common hepatic duct anteriorly (d); 
cystic artery originating from the left branch of the hepatic artery (e); cystic artery 
originating from the gastroduodenal artery (f); cystic artery arising from the celiac 
axis (g); cystic artery originating from a replaced right hepatic artery (h). 
 
HISTOLOGY 
GALLBLADDER 
The mucosa is yellowish-brown and elevated into the rugae with a 
honeycomb appearance11. In section, projections of the mucosa into the 
gallbladder lumen resemble intestinal villi, but these are not fixed 
structures and the surface flattens as the gallbladder fills with bile. 
The epithelium is a single layered columnar epithelium with apical 
microvilli. Goblet cells are absent. Beneath it is a thin fibromuscular layer 
composed of fibrous tissue mixed with smooth muscles which are 
arranged loosely in longitudinal, circular and obliquebundles. 
 
 
 
Microscopy of gallbladder wall 
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PHYSIOLOGY
17
 
Bile is made up of bile salts, 1bile pigments and other substances dissolved 
in an alkaline medium. About 500 ml is secreted daily. The glucuronides 
of the bile pigments, bilirubin and biliverdin are responsible for golden 
yellow colour1. 
 
 
 
 
 
Composition of hepatic bile 11 
 
Water 97.0
% 
Bile salts 0.7% 
Bile pigments 0.2% 
Cholesterol 0.06
% 
Inorganic salts 0.7% 
Fatty acids 0.15
% 
Lecithin 0.1% 
Fat 0.1% 
Alkaline 
phosphatase 
------- 
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REGULATION OF BILIARY SECRETION: 
The tone of sphincter of Oddi decreases when food enters mouth. Fatty 
acids and amino acids in the duodenum release CCK, which cause 
gallbladder contraction. Substances that cause contraction of gallbladder 
are called cholagogues. .The production of bile is increased by stimulation 
of the vagus nerves and by the hormone secretin 1, which increases water 
and HCO3- content of bile .  Substances that increase the secretion of bile 
are choleretics. Bile salts themselves are important choleretics 12.A 
gallbladder helps in fluid transport and its regulation. Studies have 
demonstrated that the gallbladder concentrates hepatic bile by selective 
reabsorption of bile constituents. Sodium and chloride ion are absorbed 
from the gallbladder by both active and transport mechanism, water 
absorption is thought to be passive. The secretion of the water and the 
electrolyte by the gallbladder mucosa is an active process which can take 
place against hydrostatic and osmoticgradients.22 
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There are number of gastrointestinal peptides such as cyclic AMP, 
vasoactive intestinal peptides and other peptides such as glucogon, 
cholecystokinin, neurotensin, bombaysin, motilin and stomatostatin. 
During fasting the normal bile gallbladder absorbs fluid at a rate 
corresponding to one third of fasting gallbladder volume. After feeding 
there is a reversal of the direction of gallbladder transport from net 
absorption to net secretion into the gallbladder lumen. The net water 
transport across the gallbladder may be influenced by both humoral and 
autonomic nerves.12 
The flow of bile into the gallbladder is modulated by hepatic secretory 
pressure, Sphincter of Oddi and cystic duct resistance. Only 50% of the 
secretory hepatic bile enters the gallbladder during fasting, the remaining 
bile passes into the duodenum. The CCK causes rise in the intra luminal 
gallbladder pressure to about a cm of water above that in the CBD, 
resulting in the secretion of bile into theduodenum. 12 
 Protein 1entering the duodenum also produces gallbladder contraction but 
carbohydrates produces only minimum effect. Cholecystokinin released 
from the proximal small intestine produces gallbladder contraction. 1The 
gallbladder contraction induced by the intraduodenal influence of fat 
correlates directly with the level of circulatingCCK. 21 
The role of autonomic nerve in regulating gallbladder volume is not 
clear.1
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PATHOGENESIS OF GALLSTONES 
 Gallstones can be divided into three main types: cholesterol,pigment 
 
 (brown/black) or mixed stones. In the USA andEurope 80% are cholesterol 
 
or mixed stones, whereas in Asia80% are pigment stones. Cholesterol  
 
or mixed stones contain51–99% pure cholesterol plus an admixture  
 
of calcium salts,bile acids, bile pigments and phospholipids.Cholesterol, 
 
which is insoluble in water, is secreted fromthe canalicular membrane 
 
in phospholipid vesicles. Whethercholesterol remains in solution depends  
 
on the concentrationof phospholipids and bile acids in the bile, and on the 
 
type ofphospholipid and bile acid. Micelles formed by the phospholipid 
 
hold cholesterol in a stable thermodynamic state. Whenbile is supersaturated  
 
with cholesterol or bile acid concentrationsare low, unstable unilamellar 
 
phospholipid vesicles form,from which cholesterol crystals may nucleate, and  
 
stones may form. The process of gallstone formation is complex and many areas  
 
remain unclear. Obesity, high-caloricdiets and certain medications (e.g. oral  
 
contraceptives) canincrease secretion of cholesterol and supersaturate the 
 
bile,increasing the lithogenicity of bile. Resection of the terminalileum, which  
 
diminishes the enterohepatic circulation, willdeplete the bile acid pool and result  
 
in cholesterol supersaturation.Nucleation of cholesterol monohydrate crystals  
 
frommultilamellar vesicles is a crucial step in gallstone formation. 
 
Abnormal emptying of the gallbladder may aid the aggregationof nucleated  
 
cholesterol crystals; hence, removing gallstoneswithout removing the gallbladder  
24  
inevitability leads togallstone recurrence. 
 
Pigment stone is the name used for stones containing<30% cholesterol.  
 
There are two types: black and brown.Black stones are largely composed 
 
of an insoluble bilirubinpigment polymer mixed with calcium phosphate  
 
and calciumbicarbonate. Overall, 20–30% of stones are black. The incidence 
 
rises with age. Black stones are associated with haemolysis,usually hereditary  
 
spherocytosis or sickle cell disease. Forreasons that are unclear, patients with  
 
cirrhosis have a higherinstance of pigmented stones.Brown pigment stones  
 
contain calcium bilirubinate, calciumpalmitate and calcium stearate, as well  
 
as cholesterol.Brown stones are rare in the gallbladder. They form in the 
 
bile duct and are related to bile stasis and infected bile. Stoneformation is  
 
related to the deconjugation of bilirubin deglucuronideby bacterial β- 
 
glucuronidase. Insoluble unconjugatedbilirubinate precipitates. Brown  
 
pigment stones arealso associated with the presence of foreign bodies within  
 
thebile ducts such as endoprostheses (stents) or parasites such asClonorchis 
 
sinensisand Ascarislumbricoides. 
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EPIDEMIOLOGY OF GALLSTONES 
 
 
Gallstones are a major cause of morbidity and mortality throughout the 
world. 18 
 
AGE 
At least 10 percent of adults have gallstones. The prevalence varies with 
age, sex, and ethnic group. There is an increasing prevalence with age, 
after the age of 40 about 10 to 15 percent of men and 20 to 40 percent of 
women have gallstones.19 
 
SEX 
Female: male ratio of about 2:1 in the younger age groups and the risk of 
gallstones are also associated with a history of childbearing, 20 estrogen-
replacement therapy, and oral-contraceptive use, but not diabetes 
mellitus.12 
 
PLACE 
The prevalence of gallstones is especially high in the Scandinavian 
countries and Chile. North Indians have 7 times higher occurrence of gall 
stone as compared with south Indians [2] 
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OBESITY 
It is higher in markedly obese persons and in those who lose weight 
rapidly.32There is little agreement about the effect of dietary components 
on the risk of gallstones. Fasting is normally associated with increased 
biliary cholesterol saturation and this phenomenon more accentuated in 
obesity.7Obesity also reduces gallbladder emptying. ` 
 
ESTROGEN AND CHOLESTEROL LOWERING AGENTS 
Excess estrogen from pregnancy, hormone replacement therapy, or birth 
control pills appears to increase cholesterol levels in bile and decrease 
gallbladder movement, both of which can lead to gallstones 22. Drugs that 
lower cholesterol levels in the blood actually increase the amount of 
cholesterol secreted in bile. This in turn can increase the risk of 
cholesterol gallstones. Clofibrate increases biliary cholesterol and results 
in formation of the gall stone. 1 
 
 DIABETIS MELLITUS 
Gallbladder atony consequent upon an autonomic neuropathy may favour 
stone formation in super saturated bile. 7 It has been stated that the diabetes 
patients have higher incidence of gallstone disease and are particularly 
prone to complications from there stone. 7 
 
 FASTING 
Fasting decreases gallbladder movement causing the bile to become over 
concentrated with cholesterol, which can lead to gallstones. No clear 
relationship has been proved between diet and gallstone formation.23 
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CIRRHOSIS OF THE LIVER 
Patients with cirrhosis have 3 times greater risk for gallstones than the 
normal people. The stones are usually of pigment type and probably 
results from the chronic haemolysis. 24 
VAGOTOMY 
Early clinical study suggested that truncalvagotomy was associated with 
two fold increase in the incidence of gallstones; other studies have failed 
to confirm this hypothesis. Ultrasonography suggested that 
truncalvagatomy is associated with dilated gallbladder.
6
 Nerve fibres 
from both vagal nerves merge to form the hepatic plexus which supplies 
parasympathetic motor nerves to the extra hepatic biliary system. 25 
TOTAL PARENTERAL NUTRITION AND GALLSTONE FORMATION 
Symptomatic gallstone disease forms in approximately 45% of patients 
who are maintained on long term TPN. 3 
INFLAMMATORY BOWEL DISEASE 
Patients with ileal dysfunction which is more saturated with cholesterol 
and patients with jejuno-ileal operation are associated with increased risk 
of gallstone formation [7]. 
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Whentheileumisdiseasedorremovedabsorptionofbilesaltsisimpairedandasi
gnificant loss of bile salts will occur, as result of loss of bile salts there 
will be relative increase in cholesterol leading to the gall stone formation. 41 
MISCELLANEOUS 
The prevalence of gallstones in thalassaemia is about 10%, in sickle cell 
disease is 10% to 40%, and in hereditary spherocytosis is 43% to 66%. . 
Pigment gallstones are reported in 58% of patients with homozygous 
sickle disease and in 17% of the patients with heterozygous type. 
Hormonal changes during pregnancy and alteration of gallbladder 
motility by progesterone are thought to be responsible for the 
development of gallstones in women. There is no increased risk of 
morbidity if surgical therapy for biliary disease is carried out in the 
secondtrimester.52There is a controversy over an association between the 
gallstone and colorectal cancer and gastric cancer.
58
 There is an 
association between hiatal hernia and diverticular disease of the colon and 
gallstone.71 
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CLINICAL MANIFESTATION 
 
 
PRESENTATION 
Two thirds of gallstones are asymptomatic. Risk factors for stones 
becoming symptomatic are smoking and parity. 1Asymptomatic gall stone 
disease has a benign natural course; the progression of asymptomatic to 
symptomatic disease is relatively low, ranging from 10 to25%. 97Some 
patients may present with non specific symptoms. Stones may cause acute 
or chronic cholecystitis, biliary colic, pancreatitis or obstructive jaundice. 
 
The most common presenting symptom is intermittent pain below the 
right ribcage. Pain might radiate to the back, and to the shoulder 13. 
Nausea, with or without vomiting and dyspepsia might be present. 
Certain foods, especially those with high fat content, can provoke 
symptoms. The patient might experience episodes of acute abdominal 
pain, called biliary colic. Attacks may be separated by weeks, months, or 
even years. Once a true attack occurs, subsequent attacks are much more 
likely.7,6 William et al have confirmed biliary pain as the main symptom of 
gallstone disease. He also confirmed that the gallbladder itself, without 
stones can produce pain and this pain is relieved in 77% of patients by 
cholecystectomy.6 1 
 
OBSTRUCTIVE JAUNDICE 
Large stone in Hartmann's pouch compresses the common hepatic duct 
(Mirrizi's syndrome). 
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Gallstones may also interfere with the flow of digestive fluids secreted 
from the pancreas into the small intestine, leading to pancreatitis. 
Prolonged blockage of any of these ducts can cause severe damage to the 
gallbladder, liver, or pancreas, which can be fatal. 13 
Charcot‗s triad (right upper quadrant pain, fever, and intermittent 
jaundice) is associated with common bile duct obstruction and 
cholangitis. Additional symptoms, such as alterations in the mental status 
and hypotension, indicate Raynaud‗s pentad, a harbinger of worsening 
ascending cholangitis. Other conditions like peptic ulcer, pancreatitis and 
hiatus harnia should be ruled out in patient presenting with dyspepsia 55. 
 
PHYSICAL SIGNS 
Discomfort might be elicited on deep palpation of the right upper 
quadrant of the abdomen. Murphy‗s sign (pain on palpation of the right 
upper quadrant when the patient inhales) might indicate acute 
cholecystitis.. Other signs of cholecystitis include fever and tachycardia. 
An enlarged gallbladder may be palpated when a mucocele or empyema 
of the gallbladder is present, the gallbladder is felt as tense globular 
swelling projecting downwards and lateral to the right rectus abdominus 
muscle. Hyperaesthesia between the 9th and 11th ribs posteriarly on the 
right side is present in acute cholecystitis, is called as Boas‗s sign. 12 
Complete or partial obstruction of the common bile duct. Manifests as 
jaundice. Severe hemorrhagic pancreatitis occurs in 15% patients and 
carries a high mortality rate because of multisystem organ failure. In a 
few patients, the hemorrhagic pancreatic process and bleeding into the 
fascial plane induce discoloration around the umbilicus (Cullen sign) or 
the flank (Grey-Turner sign)23. 
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COMPLICATIONS OF GALLSTONES 
In the gall bladder12: 
 Acutecholecystitis 
 Chroniccholecystitis 
 Gangrene 
 Perforation 
 Empyema 
 Mucocele(hydrops) 
 Carcinoma 
In the bile ducts17: 
 Obstructivejaundice 
 Cholangitis 
 Acutepancreatitis 
In the intestine33: 
 Acute intestinal obstruction (‗gallstoneileus) 
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MIRIZZI'S SYNDROME: Mirizzi‗s syndrome is a rare complication of 
chronic cholecystitis and cholelithiasis occurs in less than 1%. Originally 
described by Kehr and Ruge, it is later named by Mirizzi in 
1948.
101
Mirizzi and others described the presence of four features 
including a parallel cystic duct; gallstones impacted in the neck of 
gallbladder or cystic duct, causing common hepatic obstruction; and 
recurrent cholangitis. It was thought to be a functional disorder of a 
putative sphincter within the common bile duct. It is now well known that 
jaundice is caused by external compression of the common bile duct. 
McSherry in 1982 subclassifiedMirizzi syndrome into two types based on 
ERCP. Type I being an extensive compression of the common bile duct 
by a stone in the cystic duct or Hartmann‗s pouch and type II being a 
cholecystocholedochal fistula resulting from calculus erosion into the 
common bile duct. Based on this Bear et al suggested a standardized 
surgical approach to Mirizzi syndrome. A unifying classification has 
subsequently been proposed by Casendes.
102
 Type I lesions are those with 
external compression of the common bile duct, in type II lesion a 
cholecystobiliary fistula is present with erosion of less than 1/3
rd
 
circumference of the bile duct@. In type III the fistula involves upto 2/3
rd
 
of the circumferenceQ, type IV being a complete destruction of the 
common bile duct wall@. The patients usually present with acute or 
chronic cholecystitis or obstructive jaundice. This anatomical distortion 
does not allow a definitive preoperative diagnosis by ultrasound. A high 
index of suspicion is required to arrive at a correct diagnosis 
preoperatively. Direct cholangiography is more informative than USG for 
diagnosis though USG the best screening procedure. PTC and ERCP are 
important in comforming the diagnosis.  
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 CARCINOMA GALLBLADDER: Malignant change in the 
gallbladder is the fifth commonest cause of carcinoma in the 
gastrointestinal tract. The male to female ratiois  1:4.  The  majority  of  
cases  are  associatedwithgallstones.Q 
 
CHOLANGITIS: Acute cholangitis, which usually presents as a 
combination of fever, rigors and jaundice (Charcot's triad), is a serious 
and potentially lethal condition. It is caused by complete or partial biliary 
obstruction in combination with ascending infection of the biliary 
tree.Acutesuppurative cholangitis is a rare subgroup in which pus is under 
tension within the biliary tree, causing a profound illness with Gram-
negative septicemia. It requires high-dose antibiotics and urgent 
decompression of the bile ducts. This may be achieved by passing a small 
plastic catheter via an endoscope through the Ampulla of 
Vater above the site of the obstruction. 
 
BILIARY PANCREATITIS: Acute pancreatitis is caused by gallstones 
in 13-19% of patients. Small gallstones are particularly liable to cause 
this complication and there is now evidence that an attack is due to the 
impaction or passage of a stone through the Ampulla of Vater - the data 
have been obtained from routine examination of feces or from endoscopic 
appearances. Diagnosis is based on an elevated serum amylase, the 
ultrasonic demonstration of gallbladder stones and the absence ofalcohol 
ingestion.QTheacceptedmanagement plan for the majority of patients 
 
withpancreatitis of biliary origin is early ERCP, with or without  endoscopic  
 
sphincterotomy and  laparoscopic  cholecystectomy 
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GALLSTONE ILEUS: Gallstone ileus accounts for 1-4% of all cases of 
intestinal obstruction, with its incidence rising with age of patients. There 
is often a long delay between onset of symptoms (usually abdominal pain, 
vomiting, and boweldistension) and proper treatment, with a simple 
enterolithotomy as one ofthechoice. Atypical gallstone ileus may present 
as a complication of acute cholecystitis, with continuous vomiting as the 
only symptom of a subileus. 
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INVESTIGATIONS 
IMAGING STUDIES 
 
ULTRASOUND 
Sonography was introduced in the mid 1970‗s. Ultrasound (US) is the 
simplest and most reliable method for diagnosis of gallstones
.7
 US is the 
most sensitive and  specific test for the detection ofgallstones.q 
US provide information about the size of the common bile duct and 
hepatic duct and the status of liver parenchyma and the pancreas. 
Thickening of the gallbladder wall and the presence of pericholecystic 
fluid are radiographic signs of acute cholecystitis. The limitation of 
ultrasound in stone detection apart from very small stones, are the 
difficulty in estimating the size and number of stones and in detecting 
whether they arecalcified.
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Endoscopic ultrasonography is useful for detecting small gallbladder 
stones missed on transabdominol imaging, especially those located in the 
neck of the  gallbladder, where duodenal gas can obscure the image when 
scanningpercutaneously.
7
 
 
Multiple gallstones noted within the gallbladder. 
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ABDOMINAL RADIOGRAPHY 
Upright and supine abdominal radiographs are of limited value in 
identifying gallstones. Approximately 10% of gallstones are radiopaque 
and can be visualized on plain x-ray. Plane film may show a lucent 
triradiate appearance resembling a symbol of a Mercedes Benz 
automobile. Q 
RADIOISOTOPES SCAN 
HIDA scan identifies an obstructed gallbladder (eg, gallstone impacted in 
the neck of the gallbladder).HIDA scan is the most sensitive and specific 
test for acute cholecystitis.@ A poorly contracting gallbladder (biliary 
dyskinesia) might cause the patient's symptoms, and HIDA scan makes 
the diagnosis.Q 
COMPUTED TOMOGRAPHY 
CT scanning often is used in workup of abdominal pain without specific 
localizing signs or symptoms. CT scanning is not a first-line study for 
detection of gallstones.@ 
 
Computed tomography scan demonstrating a gallstone 
within the gallbladder 
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PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY 
With fluoroscopic , guidance a needle (the Chiba or Okuda needle)is 
advanced into the liver through the image guidance. The stylet is then 
removed, and contrast is injected and the needle is slowly withdrawn until 
contrast starts entering a biliary radical. This investigation is used to 
know the site of biliary obstruction, dilated bile ducts, biliary enteric or 
biliary cutaneous fistulas, level of bile leak, and to place the biliary 
stents.
7@22
 
 
MAGNETIC RESONANCE IMAGING 
Gallstones are easily identifiable on T2W images as well as on MRCP 
sequences. Choledocholithiasis can be effectively imaged by MRCP.
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MRCP can also be obtained to evaluate if retained stones are present post 
cholecystectomy. If no stones are present on the MRCP this may negate 
the need for an ERCP.
7
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ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY 
This technique remains widely used as both a diagnostic and 
a therapeutic modality. Using a side-viewing endoscope the 
ampulla of Vater can be identified and cannulated. Injection 
of water-soluble contrast directly into the bile duct provides 
excellent images of the ductal anatomy and 
can identify causes of obstruction such as calculi or malignant stricturesThe. 
commonest significant complications are  biliary  
leakage, sepsis andhemorrhage.QThe complications of ERCP include acute  
pancreatitis. Necrotising pancreatitis is a very severe complication. The most  
serious complication is the development of post procedure cholangitis.7@ 
 
Endoscopic retrograde cholangiopancreatography: 
partial occlusion of the bile duct by a malignant stricture (arrow).
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PEROPERATIVE CHOLANGIOGRAPHY 
There are various types of cholangiography performed intraoperatively, 
in the most common type the cystic duct is opened and a fine polythene 
catheter is passed through it into the common bile duct for 3 cm. A 
ligature is tied around the cystic duct and catheter which prevents 
leakage. The catheter is filled with physiological saline before insertion, 
so that there is no air bubbles present which would have a similar 
radiographic appearance to radiolucent gallstone. Instrument and packs 
which might obscure the radiograph are removed. The table is tilted to 10 
degrees right side so that the spine and ducts are not super imposed and 
20 degrees head down to ensure contrast flows into the liver. 3 injections 
of 25% Hypaque are given. A radiographic 
exposurefollowseachinjection.Anormalcholangiogramissufficientevidentt
hatexploration of the CBD is unnecessary. Failure of contrast to enter the 
duodenum may be due to sphincter spasm rather than organic lesion.
25
 
 
T tube cholangiography is performed 10 days to 14 days after 
choledochotomy via the T tube. The absence of stones and a normal flow 
of bile into the duodenum indicate that the T tube can beremoved.
252
 
 
 
OPERATIVE BILIARY ENDOSCOPY 
At the operation a rigid or flexible fibre optic endoscope can be passed 
into biliary tree. Stone can be identified and removed under direct vision. 
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TREATMENT 
There are various treatments available for treatment of gallstones but 
cholecystectomy still remains the gold standard. 
 
NON INVASIVE TREATMENT OF GALLSTONES 
68
 
1. Oral dissolutiontherapy 
2. Extracorporeal shock wave lithotripsy.(ESWL) 
 
 
MINIMALLY INVASIVE GALLBLADDER PROCEDURE 
1. Percutaneouscholecystostomy 
2. Contact dissolutiontherapy 
3. Percutaneouscholecystolithotomy 
4. Laparoscopiccholecystectomy 
 
 
INVASIVE PROCEDURE 
1. Open cholecystectomy. 
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MINIMALLY INVASIVE GALLBLADDER PROCEDURE 
 
 
PERCUTANEOUS CHOLECYSTOSTOMY. 
Percutaneous cholecystostomy is an intervention that may be used in 
moribund patients  who cannot tolerate immediate surgery, particularly in 
elderly people and high risk patients, for the treatment of acute 
cholecystitis, empyema and the perforated gallbladder with localized 
abscess formation.
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Drainage of the gallbladder produces symptomatic 
relief.
8dr
Drainage tube kept and fixed followed by cholecystectomy. 
 
CONTACT DISSOLUTION THERAPY 
Various solutions are effective in dissolving stones within the biliary tree 
when direct asses to the stone are available via a tube. These substances 
are likely to be effective only in dissolving cholesterol stones. Success 
with such an approach depends upon the compound‗s ability to dissolve 
the main constituents of the stone and good contact with thestone.
Q 
SODIUM CHLORATE 
MONO OCTANOIN 
METHYL TERT BUTYL ETHER 
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PERCUTANEOUS CHOLECYSTOLITHOTOMY 
Percutaneous cholecystolithotomy was originally described in 1985 in 
poor risk patients with acute cholecystitis. After dilatation of the 
transhepaticcholecystostomy tract, stones are removed in one to five 
sessions using baskets or forceps. The standard approach is transhepatic, 
but large cannula which makes stone extraction easier, cause unnecessary 
trauma to the liver. It is performed under general anaesthesia or local 
anaesthesia with intravenous sedation andQ. Percutaneous 
cholecystography is performed and then the fundus of the gallbladder is 
punctured with a Kellett needle, using a combination of 
ultrasonongraphic and fluoroscopic guidance. A guide is placed in the 
gallbladder for the entire procedure as a safety measure. The track is 
dilated to 28-30Fr using Teflon and telescopic metal dilators before 
inserting an Amplatz Teflon sheath. The gallbladder is inspected with  a 
rigid cholecystoscope and stones of up to 10mm in diameter are flushed 
out or removed with the forceps. Stones that are too large to pass through 
the Amplatz sheath can be fragmented by intracorporeal electrohydraulic, 
laser or ultrasound lithotripsy and removed piecemeal. At the end of the 
procedure, a Foley‗s catheter is introduced through the Amplatz sheath 
and placed on free drainage for 10 days. A tubogram is performed and the 
catheter is removed provided that the biliary tree is free of stones and 
there is no intraperitoneal extravasation ofcontrast.
68,7
 
 
 
CHOLECYSTECTOMY 
We must bear in mind that the gallbladder must be removed not 
because it contains stone, but because it forms them.
90
 
Patients having cholelithiasis with acute cholecystitis require 
cholecystectomy, unless this is impossible because of the patient's 
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medical condition. 
Prophylactic cholecystectomy for gallstones has been recommended in 
specific groups, such as children, because symptoms develop in almost all 
patients. It has also been recommended in patients with gallstones and 
sickle cell disease, because the symptoms of gallstones can mimic those 
of sickle cell crisis, and elective cholecystectomy is much safer than 
emergency cholecystectomy in this group.  
Incidental cholecystectomy for cholelithiasis is often performed 
concomitantly with surgery for morbid obesity, in view of the high 
incidence of symptomatic gallstones during rapid weight loss.
Q
 
OPEN SURGICAL CHOLECYSTECTOMY.
6
 
First described in 1882 by Langenbuch, open cholecystectomy (OC) has 
been the primary treatment of gallstone disease for most of the past 
century.The greatest drawbacks to open cholecystectomy are the resulting 
pain and weeks of disability. Antibiotics prophylaxis is employed, a 
single dose being given at the time of anaesthetic premedication. 
Preparation for operation 
After appropriate history taking and assessment of thepatient‘s  
fitness for the procedure, a full blood count andbiochemical profile 
should be performed to exclude anaemiaand to identify abnormal liver function. 
A blood coagulationscreen should be checked if there is a history of jaundice or 
liver function is abnormal. Prophylactic antibiotics should beadministered  
either with the premedication or at the time ofinduction of anaesthesia. 
 A second-generation cephalosporin is appropriate. Subcutaneous 
heparin or antiembolicstockingsshould be prescribed. The patient must sign a 
consentform to indicate that he or she is fully aware of the procedure 
being undertaken, alternative options and the risks involvedand 
complications that may occur. 
 
ANAESTHESIA 
General anaesthesiaQ 
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POSITION OF PATIENT 
The patient is placed in supine position 
 
INCISION 
Right Kocher‗s right subcostal, upper paramedian, or a midline incision.  
 
Usually right Kocher‗s incision is placed  and deepened rectus opened 
peritoneum entered. Retractors placed in position to retract liver and 
colon. Decompression of gallbladder done when its distended. Meticulous 
dissection carried out to identify cystic duct, cystic artery, CBD to avoid 
injury. Cystic duct and artery clamped cut ligated and gall bladder 
dissected from its bed. 
In fundus first method fundus grasped and dissected from its bed and 
triangele of safety viewed. 
 
 
In acute cholecystitis subtotal cholecystectomy performed to avoid CBD 
and vital structure injury. 
 
 The surgeon introduces the left index finger into the foramen of Winslow 
and thoroughly palpatesforcalculiinthecommonbileduct.The subhepatic 
space is irrigated with warm saline and all irrigation fluid is evacuated. 
The incision is usually closed in one or two layers. The skin can be closed 
with skinstaples. 
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Ligation of cystic duct and arter 
 
 
 
 
Palpation of the lower end of CBD and pancreas 
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Post operative complications: 
Wound infection , bleeding, lower lobe atlectasis, electrolye imbalance, 
bile duct injury. 
Postcholecystectomy syndrome refers to the persistence of symptoms 
referable to the biliary tract after cholecystectomy. As currently defined, 
the syndromes exclude those patients whose symtoms are due to organic 
disease outside the biliary tract.  
There is a female preponderance, particularly in the 40-50 years age 
group. A careful evaluation and a full investigation of the biliary tract 
including an ERCP are advisible in all patients with persistence or 
recurrence of symptoms after cholecystectomy.
3
 The common causes of 
post- cholecystectomy syndromesare:@@@ 
 
 Retained or recurrentcalculi@ 
 Gall bladder/cystic duct remnants@ 
 Bile duct strictures and unrecognized iatrogenicinjuries. 
 Injuries [choledochoduodenal fistula@] 
 Papillary stenosis and biliarydyskinesia.@
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LAPAROSCOPIC CHOLECYSTECTOMY 
The laparoscopic procedure has many advantages it has early recovery, 
less postoperative pain, short hospital stay, but wide learning curve as 
compare to open cholecystectomy. 
 
 
TECHNIQUE OF LAPAROSCOPIC CHOLECYSTECTOMY 
Consent:- 
Informed written consent is obtained for laparoscopic procedure, its 
complications and the need, if necessary for conversion to open 
cholecystectomy.  
 
Anaesthesia:- 
It is done under endotracheal general anaesthesiawith  monitoring of end 
tidal carbon dioxide and pulse oximetry is mandatory. 
Position:- 
 Reverse trendlenberg posture sligately rotated to left. 
Procedure:- 
Pneumoperitoneum created using verres needle through 
subumbilicalincisiononcepneumoperitoneum created 10mm trocar placed or open 
technique  under direct vision.  
30degree telescope introduced 
Other ports are introduced under vision:- 
 The right lateral 5mm port in the anterior axillary line  
 The epigastric 10mm port  
 The sub costal mid-clavicular 5mm port 
Fundus of gallbladder grssped and retracted towards shoulder for 
adequate visualization. 
Dissection and skeletonisation of cystic duct and cystic artery—Further 
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dissection is commenced by division of the peritoneal fold between 
Hartmann‗s pouch and liver.critical view of safety viewed The cystic 
artery is identified and  cystic duct is identified clipped and divided 
 
 GB is dissected off the liver bed. And takenout via epigastric port. 
 
A drain is inserted through the lateral trocar and positioned in the sub 
hepatic region. Closure  sheath is sutured with vicryl/ prolene. All skin 
incisions are closed and the drainage tube is connected to the bottle and 
covered withdressing.Q 
The gall bladder is opened and examined and sent for histopathology. 
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PortPlacement 
 
 
Calotstriangle 
 
 
Dissection of cystic duct 
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Application of clips to Cystic duct 
 
 
Dissection of GB from liver bed 
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    Gall bladder with stones 
 
COMPLICATIONS OF LAP CHOLECYTECTOMY 
 
 
A) HEMORRHAGE 
 
 
TROCAR SITEBLEEDING 
Trocar site bleeding can be prevented bymsubcutaneous vessel in 
subcutaneous tissue should be avoided during insertion. 
 
SUDDEN AND PULSATILE BLEEDING IN CALOT‗STRIANGLE 
Bleeding in the Calot‗s triangle can be prevented by careful dissection 
and proper application of clip to cystic artery. 
GALLBLADDER FOSSABLEEDING 
GB fossa bleeding can be controlled by bipolar diathermy, packing the 
site with gel foam. 
 
b) PERFORATION OFGB 
In acute cholecystitis perforation may occur due to inflammatory edema. 
Managed with saline irrigation and suctioning , extraction ofspilledstones. 
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Drain should be kept inside. 
 
c) OCCULTCARCINOMA 
In cases suspected to have carcinoma intraoperatively, frozen section is 
sent and if frozen section is positive for carcinoma, then conversion to 
open technique is considered and radical surgery with excision of port 
sites done. 
 
d)POST OPERATIVE BILELEAK 
Post operative bile leak can occur due to injury to the CBD, the right 
hepatic duct or accessory bile duct.The diagnosis can be confirmed by 
USG or ERCP. 
 
If drain is placed most of the minor leak will heal with expectant 
management. In some persistent cases, it may be advisable to decrease the 
intraductal pressure by nasobiliary drainage, endoscopic spincterotomy or 
transpapillary stenting. 
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e) BILE DUCTINJURY 
Incidence of CBD injury during LC exceeds that of open cholecystectomy 
i.e0.5% vs 0.2%.
123
 Reasons for the increase in injury during LC included 
loss of hepatic information, incorrect traction forces to the gallbladder 
and injudicious use of cautery inside of the triangle of Calot. Risk factors 
that increase the risk of CBD injury include acute cholecystitis, aberrant 
anatomy. The most common anatomic variant is an aberrant right hepatic 
duct. 
 
CLASSIFICATION 
The Stewart-Way classification is derived from analysis of a series of 
LC-associated CBD injuries. 
Stewart- Way classification of bile duct injury 
 
 
 
It is managed by biliary enteric anastomosis. This is to prevent 
cholangitis and biliary strictures. 
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f) BOWELINJURY 
Injury to bowel can occur during trocar insertion or dissection in the right 
upper quadrant, especially when using electrosurgical devices. The 
jejunum, ileum and colon can be injured by Veress needle and trocars, 
while duodenum is likely to be injured during dissection. Any structure 
fixed to the under surface of the umbilicus like the urachus or a meckel‗s 
diverticulum is more susceptible to injuryduringacess. 
 
g) WOUND INFECTION AND INCISIONALHERNIA 
The risk of wound infection following laparoscopic cholecystectomy is 
less than 1% and the risk of incisional hernia is 0.5%.
115 
          
         h)DIAPHRAGMATIC INJURY 
Diaphragmatic injury may be due to either cautery or by mechanical 
puncture by an instrument.
126,127
 
 
         i)PANCREATITIS 
 
j)PNEUMOPERITONEUM RELATEDCOMPLICATIONS 
Embolism 
vasovagal reflex, 
cardiac arrhythmias and  
hypercapniaacidosis.@ 
gg 
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ADVANTAGES AND DISADVANTAGES OF LC COMPARED TO 
OC 
 
 
 Advantages and disadvantages of lc compared to oc 
 
ADVANTAGES DISADVANTAGES 
Less post operative pain Lack of depth perception 
Smaller incision View controlled by camera 
operator 
Better cosmesis More difficult to control 
hemorrhage 
Shorter hospitalization Decreased tactile discrimination 
(haptics) 
Earlier return to full 
activity 
Potential CO2 insufflation 
complications 
Decreased total costs Adhesions/inflammation limit use 
 Slight increase in bile duct injury 
 
CONVERSION In 5-10% of cases, conversion to open cholecystectomy 
may be needed for safe removal of gallbladder.@
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MATERIALS AND METHODS 
 
This   dissertation   titled   as   ―A   clinical   study   and   management   of 
cholelithiasis‖ was done at GovtRoyapettah Hospital, Kilpauk medical 
College and  Hospital, Chennai-10. 
 
About 53 consecutive cases were admitted, examined, investigated and 
operated during the period of Jan 2018 to June  2018. Detailed history of 
all the 53 cases were taken according to the proforma approved by the 
guide. All patients underwent detailed examination and  
Investigationsdone.Risk and complications of the condition as well as 
surgery was explained to the patients, consent was taken. 
 
In this study some patients underwent open cholecystectomy and some of 
the patients underwent lap cholecystectomy 
 
Inclusion criteria: 1. Symptomatic gall stones disease with or without 
complications likeQ 
a. acute and chroniccholecystitis 
b. mucocele of the gallbladder 
c. empyema of the gallbladder 
d. perforation 
e. pancreatitisQ
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2. asymptomatic gall stones of size more than2.5cm 
3. patients with stones both in the gall bladder and the common 
bileduct 
 
 
Exclusion criteria:Q 
 
1. Primary CBD stones with outgallstones 
2. Comorbid conditions like cardiac disease 
and renal failure 
3. Asymptomatic gallstones of size less than2.5cm 
4. Gall bladder stones with congenital malformations of the 
biliary tree or stricture of theCBD. 
 
SURGICAL PROCEDURE: 
 
Open Cholecystectomy: A sub costal muscle transection incision was used 
for open cholecystectomy; the length of the incision was tailored to the 
individual patient and kept to the minimum necessary to allow safe and 
adequate access to the gall bladder. Dissection was started at Calot‗s 
triangle and proceeded antegradely towards the fundus. ―Fundus first 
method‖ was used in case of dense adhesions where anatomy of Calot‗s 
triangle was not clear. Based on clinical investigation and operative 
criteria, exploration of the CBD was done. 
 
Laparoscopic Cholecystectomy: Laparoscopic cholecystectomy was 
performed with the operating surgeon on the left side of the table. 
Pneumoperitoneum was created using Veress needle and by Hassan‗s 
technique in some cases. It involved two 10mm and two 5mm trocars. 
Peritoneal cavity was visualized and any adhesions if present were 
released. Calot‗s triangle was visualized and dissection was carried out  
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by means of electrocautery and the cystic duct and artery were secured 
with titanium clips. At the completion of the operation, a sub hepatic 
drain was inserted as required in both the groups.sAll patients were 
administered NSAID‗s and anti-emetics as required. Patients were 
allowed liquids once bowel sounds returned. Patients were discharged 
from the hospital once they were fully mobilized and able to tolerate a 
normal diet and pain relief was adequate. Pain in the post op period was 
rated for each patient using a Visual Analogue Scale (from 0 to 5). 
Data was collected prospectively and included in patient‗s demographics. 
 
 
Laboratory results, operative findings, requirement for conversion to open 
cholecystectomy, operating time (from incision to closure), operative 
complications, duration of post operative pain, analgesic administration 
and length of hospital stay along with post-operative complications if any 
were recorded. 
Patients were encouraged to resume work and normal daily activity as 
soon as possible. Evaluation of return to normal work was made during 
an OPD appointment 4 weeks aftersurgery. 
59  
 
 
 
 
OBSERVATIONS & RESULTS 
 
Our study is the prospective study of Clinical Study and Management of 
Cholelithiasis. It included 53 cases, presenting with symptoms of gall 
stones, confirmed with imaging techniques and admitted to the 
department of surgery of Government Royapettah Hospital, Kilpauk 
Medical College and Research Hospital, Chennai. Duration of study was 
from Jan 2018 to June 2018 
Table : Sex wise distribution of the cases in our study. 
  Frequency Percent 
Valid Female 32 60.4 
Male 21 39.6 
Total 53 100.0 
 
 
.  
In the present study 32 (60.4%) patients were female and 21 (39.6%) 
patients were male. The study shows that gallstones disease is a common 
problem in female population. The female to male ratio is 1.52:1. 
Gender distribution
Female Male
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Age Range Groups: 
 
In this study there was a increased incidence of cholelithiasis in the 4
th
 
decade, even though no age group was exempt from the disease process 
CLINICAL SYMPTOMS: 
 Right upper quadrent pain is the most common symptom present in 52(98.1%) 
cases. Fever in 14 (26.4%) cases, vomiting and dyspepsia seen in 22(41.5%) cases . 
Jaundice present in 4(&.5%)cases. 
 
 
 
 
 
 
 
 
P - 
Value ** Highly Significant at P ≤ .01 
   
 
 
       
 
P - 
Value * Significant at 0.01 < P ≤ .050 
   
 
 
       
 
P -
Value # No Significant at P >.050 
   
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
26 - 35 yrs 36 - 45 yrs 46 - 55 yrs 56 - 65 yrs Above 65 
yrs
Age Range distribution
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0%
20%
40%
60%
80%
100%
LC OC
Gender with Groups
Female Male
 LC OC 
Female 60.0% 61.1% 
Male 40.0% 38.9% 
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PER OP COMP * 
Groups 
    
      Crosstab 
  
Groups 
Total LC OC 
PER OP 
COMP 
BL Count 1 2 3 
% 
within 
Groups 
2.9% 11.1% 5.7% 
No Count 32 16 48 
% 
within 
Groups 
91.4% 88.9% 90.6% 
SS Count 2 0 2 
% 
within 
Groups 
5.7% 0.0% 3.8% 
Total Count 35 18 53 
% 
within 
Groups 
100.0% 100.0% 100.0% 
      Chi-Square Tests 
  
  Value df 
Asymp. 
Sig. (2-
sided) 
  Pearson 
Chi-
Square 
2.468
a
 2 .291 
  Likelihood 
Ratio 
2.999 2 .223 
  N of Valid 
Cases 
53     
  a. 4 cells (66.7%) have expected count 
less than 5. The minimum expected 
count is .68. 
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0%
20%
40%
60%
80%
100%
LC OC
Pre Op Complication with Groups
BL SS No
 LC OC 
BL 2.9% 11.1% 
SS 91.4% 88.9% 
No 5.7% 0.0% 
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Age range * Groups 
    
      Crosstab 
  
Groups 
Total LC OC 
Agerange 26 - 35 
yrs 
Count 4 5 9 
% 
within 
Groups 
11.4% 27.8% 17.0% 
36 - 45 
yrs 
Count 11 5 16 
% 
within 
Groups 
31.4% 27.8% 30.2% 
46 - 55 
yrs 
Count 10 4 14 
% 
within 
Groups 
28.6% 22.2% 26.4% 
56 - 65 
yrs 
Count 9 1 10 
% 
within 
Groups 
25.7% 5.6% 18.9% 
Above 
65 yrs 
Count 1 3 4 
% 
within 
Groups 
2.9% 16.7% 7.5% 
Total Count 35 18 53 
% 
within 
Groups 
100.0% 100.0% 100.0% 
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Chi-Square Tests 
  Value df 
Asymp. 
Sig. (2-
sided) 
  Pearson 
Chi-Square 
7.669
a
 4 .104 
  Likelihood 
Ratio 
7.931 4 .094 
  Linear-by-
Linear 
Association 
.394 1 .530 
  N of Valid 
Cases 
53     
  a. 5 cells (50.0%) have expected count 
less than 5. The minimum expected count 
is 1.36. 
   
 LC OC 
26 - 
35 yrs 
11.4% 27.8% 
36 - 
45 yrs 
31.4% 27.8% 
46 - 
55 yrs 
28.6% 22.2% 
56 - 
65 yrs 
25.7% 5.6% 
Above 
65 yrs 
2.9% 16.7% 
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T-Test 
           
            Group Statistics 
      
Groups N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
      Age LC 35 48.43 10.556 1.784 
      OC 18 47.06 13.549 3.194 
      DURATION LC 35 88.43 16.214 2.741 
      OC 18 103.89 25.003 5.893 
      VAS LC 35 2.60 .695 .117 
      OC 18 3.28 .669 .158 
      PAIN DUR LC 35 4.00 1.237 .209 
      OC 18 5.17 1.465 .345 
      ANALGESICS LC 35 5.06 1.830 .309 
      OC 18 6.94 1.626 .383 
      Days in 
Hospital 
LC 35 8.09 2.832 .479 
      OC 18 11.44 3.166 .746 
      RETURN TO 
NORMAL 
WORK 
LC 35 9.49 2.737 .463 
      OC 18 13.17 3.330 .785 
      
            
 
0%
20%
40%
60%
80%
100%
LC OC
Age with Groups
26 - 35 yrs 36 - 45 yrs 46 - 55 yrs 56 - 65 yrs Above 65 yrs
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Independent Samples Test 
  
Levene's Test 
for Equality of 
Variances t-test for Equality of Means 
 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
 Lower Upper 
 Age Equal 
variances 
assumed 
2.277 .137 .407 51 .686 1.373 3.376 -5.405 8.151 
 Equal 
variances 
not 
assumed 
    .375 27.910 .710 1.373 3.658 -6.122 8.868 
 DURATION Equal 
variances 
assumed 
6.921 .011 -2.721 51 .009 -15.460 5.681 -
26.866 
-4.055 
 Equal 
variances 
not 
assumed 
    -2.379 24.574 .025 -15.460 6.499 -
28.858 
-2.063 
 VAS Equal 
variances 
assumed 
.820 .369 -3.406 51 .001 -.678 .199 -1.077 -.278 
 Equal 
variances 
not 
assumed 
    -3.447 35.594 .001 -.678 .197 -1.077 -.279 
 PAIN DUR Equal 
variances 
assumed 
1.527 .222 -3.053 51 .004 -1.167 .382 -1.934 -.400 
 Equal 
variances 
not 
assumed 
    -2.890 29.741 .007 -1.167 .404 -1.991 -.342 
 ANALGESICS Equal 
variances 
assumed 
.019 .892 -3.687 51 .001 -1.887 .512 -2.915 -.860 
 Equal 
variances 
    -3.832 38.251 .000 -1.887 .493 -2.884 -.890 
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not 
assumed 
Days in 
Hospital 
Equal 
variances 
assumed 
1.768 .190 -3.928 51 .0005 -3.359 .855 -5.075 -1.642 
 Equal 
variances 
not 
assumed 
    -3.788 31.225 .001 -3.359 .887 -5.167 -1.551 
 RETURN TO 
NORMAL 
WORK 
Equal 
variances 
assumed 
2.993 .090 -4.305 51 .0005 -3.681 .855 -5.398 -1.964 
 Equal 
variances 
not 
assumed 
    -4.040 29.111 .000 -3.681 .911 -5.544 -1.818 
 
             
Groups = LC 
        
          Statistics
a
 
 
  Age DURATION VAS 
PAIN 
DUR ANALGESICS 
Days in 
Hospital 
RETURN 
TO 
NORMAL 
WORK 
 N Valid 35 35 35 35 35 35 35 
 Mean 48.43 88.43 2.60 4.00 5.06 8.09 9.49 
 Median 50.00 90.00 3.00 4.00 5.00 7.00 9.00 
 Std. Deviation 10.556 16.214 .695 1.237 1.830 2.832 2.737 
 Range 39 70 3 5 9 12 11 
 Minimum 28 60 1 3 3 4 6 
 Maximum 67 130 4 8 12 16 17 
 a. Groups = LC 
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Groups = OC 
          Statistics
a
 
 
  Age DURATION VAS 
PAIN 
DUR ANALGESICS 
Days in 
Hospital 
RETURN 
TO 
NORMAL 
WORK 
 N Valid 18 18 18 18 18 18 18 
 Mean 47.06 103.89 3.28 5.17 6.94 11.44 13.17 
 Median 43.50 100.00 3.00 5.00 7.00 10.00 12.00 
 Std. Deviation 13.549 25.003 .669 1.465 1.626 3.166 3.330 
 Range 42 80 3 5 5 8 9 
 Minimum 28 70 2 3 5 8 9 
 Maximum 70 150 5 8 10 16 18 
 a. Groups = OC 
  
 
Duration of procedure compared with both groups 
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LC 88mins  
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70  
 
Postoperative pain duration 
 
 
 
 
 Pain 
duration 
LC 4 
OC 5 
Postoperative use of analgesics 
 
0
1
2
3
4
5
6
LC OC
Pain duration
0
1
2
3
4
5
6
7
8
LC OC
Analgesic
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 Analgesic 
LC 5 
OC 7 
Postoperative hospital stay 
 
 
 Hospital 
stay 
LC 8 
OC 11 
 
 
 
 
 
 
 
 
 
0
2
4
6
8
10
12
LC OC
Hospital stay
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All cases were managed by one or the other surgical procedure as 
mentioned below. 6 patients had other co-morbid conditions like diabetes 
mellitus, hypertension, COPD. 
 
Open cholecystectomy was done in 18 (34%) patients while 35 (66%) 
patients underwent laparoscopic cholecystectomy. Of the 18 open 
cholecystectomies, Kocher‗s right subcostal incision was used in 17 
cases. Abdomen was opened in midline for 1 case of acute cholecystitis 
(75 year old male) who didn‗t improve on conservative management and 
had developed features of peritonitis. In 2 (9.5%) cases, Lap was 
converted to open cholecystectomy due to denseadhesions. 
 
Common bile duct stones were managed with cholecystectomy and 
common bile duct exploration with T- tube insertion in 2 patients 
following failure of ERCP stone extraction. In 1 case ERCP successfully 
removed the CBD stone and later patient underwent elective laparoscopic 
cholecystectomy. On table T- tube cholangiogram was done in first 2 
patients. 
Mild to moderate adhesions were noted in 30% of cases and in 10% thick 
fibrous adhesions noted. In 10% Calot‗s triangle was found difficult to 
dissect. In 90% of cases classical porta to fundus dissection (retrograde) 
was used except in 10% where Calots‗s triangle was obscured. 
Intraoperative anomalies found was short and thick cystic duct in 2 cases. 
 
40 (80%) cases had fibrosed, contracted and thickened 
gallbladder, 9(18%) cases had inflamed gallbladder 
1(2%) cases had empyema of 
gallbladder and  
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The median duration of operative procedure was 103 (70-130min) for OC 
and 88min (60-130min) for LC. The difference was not found to be 
significant. The main complications noted per operatively were bile leak 
(1patient (5.7%) in LC and 1 patients (11.1%) in OC group) and stone 
spillage (1 (5%) in LC and 1 (3%) in OC). There was no instance of CBD 
injury in either group. 
Post operative complications were minimal. 1 patient in laparoscopic and 
2 patients in open had surgical site infection. 
 
The VAS was median Grade 3.8 in OC group as compared to median 
Grade 2.6 in LC group. The pain was more in the initial 3 days in both 
groups and it lasted for median duration of 5 days in OC group compared 
to 4 days in LC group. The NSAID‗s were used for more days in OC 
group (median-6days) compared to LC group (median-4 days). 
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DISCUSSION 
 
Our study is the prospective study of Clinical study and management of 
Cholelithiasis. It included 53 cases presenting to the OPD of Department 
of Surgery with symptomatic gall stones, confirmed by imaging studies 
and admitted for further management in GovtRoyapettah Hospital, 
Kilpauk Medical College and Research Hospital, chennai. Duration of 
study was from Jan 2018 to October 2018 
Age wise distribution of the cases included in our study 
 
Our study has shown that most common age group affected by 
symptomatic gall stones was the 4
th
 decade, even though no age group 
was exempted from the disease process. This was correlated well with 
studies conducted by Herman‗s (4th decade) and Rushad‗s (4th – 5th 
decade)series. 
comparison of age-wise distribution of the cases. 
 
 
Age 
Group in 
years (yrs) 
Present 
study 
% Herman et 
al 
% Rushad et 
al 
% 
11-
20 
0 0% 25 1.60% 00 0 
21-
30 
03 5.6% 92 5.90% 04 3.33% 
31-
40 
13 24% 226 14.60
% 
36 30% 
75  
41-
50 
19 35.8
% 
325 21% 30 25% 
51-
60 
11 20.7
% 
473 30.60
% 
29 24.16
% 
>60 07 13.2
% 
352 23.57
% 
21 17.5% 
 
 
In this study cases fall between 15 – 85 Yrs. There is an increased 
incidence in the 4 & 5th decade with the maximum incidence in the 
4thdecade. 
Similar incidence is seen in the studies of Herman et al (5th decade).
129
 
Hanif.
130
 series showed peek incidence in 5th decade. In western studies 
the peak incidence is 
inthe5th&6thdecades.Theriseinthepeakageofincidenceisduetochangeinthe 
dietary factor. Similar findings are noted in the studies of Ganeyet al.
131
 
and Moreaux et al.
132
 
 
Sex wise distribution of cases included in our study 
 
:Sex wise comparison of the cases. 
 
Sex 
No. 
of 
case
s 
 
% 
Battachary
‗s 
series 
 
% 
Alokshar
ma 
 
series 
 
% 
Femal
e 
32 60.
4% 
65 71.
4 
41 70 
Male 21 39.
6% 
26 28.
6 
17 30 
 
In the present study 32 (60.4%) out of 53 cases were female while the rest 
21 (39.6%) were male. Battacharya.
133
 series showed 71.4% were female, 
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28.6% were male. Similar sex preponderance in the favour of females 
were noted by A.P.Tamhankar.
134
, Ganey et al.
131,
 Major Alok Sharma et 
al
.135,
 series showed that 70% were female & 30% were male. 
 
Clinical presentation of different cases included in our study. 
 
Our study has shown that all of the patients presented with pain in the 
right upper quadrant followed by vomiting (44%), dyspepsia (38%). 
Others also had fever and jaundice. 
Similar findings were also observed in the studies conducted by Ganey 
and AlokSharma. 
 
 
 TABLE : comparison of clinical presentation of the cases. 
 
 
Sl.No 
 
Clinical 
Presentati
on 
Present study AlokSharma
137
 Ganey
133
 
Numb
er of 
cases 
% of 
cases 
Number 
of 
cases 
% 
of 
case
s 
Numb
er of 
cases 
% 
of 
case
s 
1 Pain 52 98.
1% 
58 100% 987 95% 
2 Vomiting 22 41.
5% 
48 82.8
% 
576 55.6
% 
3 Dyspepsia 22 41.
5% 
5 8.62
% 
222 21% 
4 Feve
r 
14 26.
4% 
N
A 
00 92 09% 
5 Jaundice 04 7.5
% 
3 5.17
% 
101 10% 
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Pain was the predominant symptoms in the present study involving- 98% 
patients. The commonest site of pain was in the Rt. Hypochondrium, & 
the next commonest site was Epigastrium. 5 (10%) patients complained 
of pain radiating to the back. 38 (76%) patients had chronic Recurring 
pain and 10 (20%) patients had acute onset of pain. pain was colicky in 
nature. Similar presentations were noted in the series of Alok Sharma, 
Ganey, Goswitz et al
[115]
. 44% (22 patients) of cases in the present series 
had nausea/vomiting. 
Vomiting was spontaneous, occurred mostly during the attack of pain. 
Vomiting in this study was almost similar to Ganey et al series. In the 
present study 4 (8%) patient had jaundice. The cause of the jaundice was 
stone in the common bile duct in 3 (6%) patients, 1(2%) patient had 
features of cholangitis. The common bile duct were explored in 2 (4%) 
patients & stone were removed. 38% (19 patients) of patient had 
dyspepsia. The dyspepsia was relieved after these patients underwent 
Cholecystectomy. The incidence of dyspepsia in present series was higher 
to Ganey series and Alok Sharma series. Fever was present in13 (26%) 
cases in the present study. Fever was due to acute cholecystitis in 10 
(20%) patients and secondary tocholingitis due to biliary obstructionin 
4(8%) patients 
78  
 
 
Clinical signs of different cases included in the present study. 
 
TABLE 23: comparison of different clinical signs. 
 
Clinical 
signs 
K.L. Kapoor 
et al136 
Karl A et 
al
137
 
(N=1261) 
Present 
study 
Tenderness in 
RH/epigastrium 
89.6% 96% 96% 
Icterus 2.10% 10% 8% 
Mass 6.20% 4% 2% 
 
Tenderness in the Rt. Hypochondriam was present in all  patients which 
was similar  to Kapoor et al & Karl et al studies, guarding was present in 
15 (30%) patients. A positive Murphy‗s sign present in 8 (16%) patients. 
A Globular mass was felt in 1 (2%) patient who had empyema of the gall 
bladder. Icterus was present in 4 (8%) patients. 
 
INVESTIGATIONS 
All the patients underwent routine hematological & biochemical 
investigations. The hemoglobin of patients ranged from 8 to 15 gm %. 
Serum bilurubin was raised in 8 patients, there bilurubin levels ranged 
form 1.8 to 5 mg %.Alkaline phosphatase was raised in 8 patients
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Ultrasound Imaging study of the cases included in the present 
study.Ultrasound scanning was done in all patients. All 50 patients had stones in 
the gall bladder, 3 (6%) patient had stones in both gall bladder & common bile 
duct. 64%(32 patients) had multiple stones in gall bladder, 36% (18 patients) had 
solitary stones in gall bladder. 
Thickening of gall bladder was present in 16% (8 cases) of the cases. 
Dilatation of the common bile duct more than 1 cm was present in 3 (6%) 
patients. Many of the features in my study were similar to studies of 
major Alok Sharma etal. 
 
TABLE No. 24: Comparison of Ultrasound Imaging study of the cases. 
 
 
Sl.N
o 
 
Imaging findings 
Number 
of 
cases 
 
% of 
cases 
Alok 
Sharma
1
38
 Series 
 
% 
1 
Stones in 
gallbladder 
53 100% 57 98.
3 
2 Solitary stone 13 24.5% 15 26.
3 
3 Multiple stone 27 50.9% 42 73.
7 
4 
Gall stone with 
Bile duct 
stone 
2 3.8% 3 5.2 
5 Dilated bile duct 1 1.9% 10 17.
2 
6 
Gall bladder 
wall 
thickening 
8 16% 3 5.2 
7 Mass 0 0% 1 1.7 
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Management of the cases included in the present study. 
 
All cases were managed by one or the other surgical procedure. All 
patients who were diagnosed with chronic cholecystitis were operated 
electively by open or laparoscopic cholecystectomy.10 Patients who 
presented with acute severe symptoms were initially managed by Nil by 
mouth, nasogastric tube, broad spectrum antibiotics and analgesics.3 
patients underwent laparoscopic cholecystectomy after 3 days.2 patients 
underwent emergency open cholecystectomy of which one was 
gangrenous gall bladder with perforation and one was empyema 
gallbladder. Another patient who had palpable mass was taken for 
laparoscopic cholecystectomy but had to be converted to open surgery 
because of dense adhesions. It was confirmed to be empyema of gall 
bladder and patient underwent partial cholecystectomy. Other 5 patients 
were treated conservatively and interval cholecystectomy was done after 
6 weeks of which 4 patients underwent open cholecystectomy and 1 
patient underwent lap which was again converted to open with partial 
cholecystectomy due to dense adhesions. Three patients who had 
cholelithiasis with choledocholithiasis were managed with 
cholecystectomy with CBD exploration and T-tube insertion in two 
patients following failure of ERCP stone extraction. In one case ERCP 
successfully removed the CBD stone and the patient later underwent 
elective laparoscopic cholecystectomy. 
 
 
Laparoscopic vs open cholecystectomy 
Traditional cholecystectomy is an integral part of every surgical training 
programme and is performed by most general surgeons. The advent of 
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laparoscopic cholecystectomy has created an excitement and a flurry of 
activity in the medical community. 
This study showed that morbidity rate is more with open cholecystectomy 
than laparoscopic cholecystectomy. 
 
The operating time was almost equal in both the procedures, 103min (60-
150min) for OC and 88min (60-130min) for LC, slightly more mean time 
in Open Cholecystectomy was due to dense adhesions and in patients 
requiring CBD exploration & T-tube insertion. 
 
 
As experience is gained, an operating time of about 50 min can be 
achieved during laparoscopic cholecystectomy. This ―learning curve‖ 
represents adapting to operating in the 2-D screen, becoming familiar 
with the instrumentation and becoming accustomed to the technique. 
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In this study, there were no major complications and several minor ones. 
There was no peri-operative mortality and no CBD injury. The 
complications observed per operatively were bile leak, stone spillage and 
blood loss which were found to be comparable in both the groups. Post 
operative complications were surgical site infection, one in each 
procedure. 
 
The VAS was significantly less for LC group [Grade2 (median) for LC 
and Grade3 (median) for OC; p< 0.01]. Kum
120
 also found a mean VAS 
score of 4 v/s 5.17 between LC and OC. The pain duration (median 3 
days for LC and median 5.5 days for OC patients; p < 0.01) and the 
duration of analgesics used (median 5 days for LC and median 7 days for 
OC patients; p<0.01) also were significantly less in laparoscopic group 
patients. This was due to the lesser incision size in LC. Other studies have 
also shown similar results.
120,119
 
 
The two most beneficial aspects of LC are, the short hospital stay and the 
rapid recovery. In this study, the median duration of hospital stay was 7.5 
days for LC group and 12 days for OC group. The difference was found 
to be statistically significant (p<0.01). This was also confirmed in various 
other series.118 
 
The time taken to return to normal work was also less in LC cases than OC cases. 
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CONCLUSION 
 
 The highest age incidence of cholelithiasis was in the 4th decade, 
eventhough no age group was exempt from the disease process. 
 The incidence of cholelithiasis was more infemales. 
 
 The commonest symptom was painabdomen. 
 
 The commonest sign wastenderness. 
 
 Ultrasonogram is the imaging modality ofchoice. 
 
 The most common complication of gallstone disease was 
chroniccholecystitis. 
 
 Laparoscopic cholecystectomy is a safe and effective treatment for 
most patients with symptomaticgallstones. 
 
 One should not hesitate to convert to an OC if significant adhesions 
or inflammation are identified duringlaparoscopy. 
 
 Technically, the dissection of the cystic artery and cystic duct is 
very precise and less peri operative blood loss in 
laparoscopictechnique. 
 
 The antibiotic usage in LC is comparatively lesser than that ofOC. 
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 The degree of post operative pain and its duration isless. 
 
 The amount of analgesic requirement is less inLC. 
 
 LC patients tolerate oral feeds earlier and are mobilizedfaster. 
  The duration of hospital stay is less and patients can be discharged 
quickly from thehospital. 
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KEY TO MASTER CHART 
 
IP No In patient number 
RUQ Right Upper Quadrant 
Dysp Dyspepsia 
Prev. Hist Previous History 
OCP‗s Oral Contraceptive Pills 
RHC Right hypochondriac 
STB Serum total bilirubin 
SGPT Serum Glutamyl Phosphate Transaminase 
ALP Alkaline Phosphatase 
TC Total Cholesterol 
LC Laparascopic cholecystectomy 
OC Open Cholecystectomy 
CBDE Common Bile Duct Exploration 
HPR Histopathology Report 
F Female 
M Male 
+ Positive /Present 
- Negative /Absent 
A C Acute Cholelithiasis 
Ch. c Chronic Cholecystitis 
CC Calculus cholecystitis 
APD Acid peptic disease 
OJ Obstructive jaundice 
N Normal 
MC Multiple Calculus 
Symb C Symptomatic Cholelithiasis 
CBDS Common Bile Duct Stones 
GBC Gall Bladder calculus 
DIHBR Dilated intra hepatic bile radical 
SC Solitary Calculus 
GB Gall Bladder 
DGB Distended Gall Bladder 
ACC Acute calculus cholecystitis 
OC Laparoscopic converted to Open Cholecystectomy 
GCC Gangrenous Cholecystitis 
CCC Chronic Calculus Cholecystitis 
ACC Acute Calculus Cholecystitis 
ACCC Acute on Chronic Calculus Cholecystitis 
BL Bile leakage 
SSI Surgical site infection 
TLC Total leucocyte count 
PMN Poly morphonuclear cells 
ST Stormy recovery 
ERCP Endoscopic Retrograde Cholangiopancreatography 
SS Stone spillage 
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1 Thiyagarajan 3771 42 M  + + + + - - - - + + + - A C MC+TG+ASC OC 130 - - No BL 4 5 7 GCC NIL 15 16 UR 
2 Jamudurin 2373 43 F + - - - + + + - - - + - Ch.c MC LC 90 - - NO - 3 4 5 CCC NIL 9 10 UR 
3 Nagesh    2310 34 M + - - - - + - - - - + - Ch.c MC LC 100 - - NO - 2 3 3 CCC NIL 5 6 UR 
4 Jeyanthi 5778 38 F + - + - + - + - - - + - Ch.c SC LC 80 - - NO - 3 4 5 CCC NIL 9 10 UR 
5 Rajendran 7629 64 M  + + + + + - + - - + + - C+CDL C+CDL+IHBR OC 150 √ √ Ö - 3 8 8 CCC NIL 16 18 UR 
6 Valliyammal 7168 60 F + - - - - + + - - - + - Ch.c SC LC 100 - - NO - 3 4 5 CCC NIL 11 12 UR 
7 Thilagavathy 11202 40 F + - - - - + - - - - + - Ch.c MC LC 70 - - NO - 2 3 5 CCC NIL 10 11 UR 
8 pushpa 14428 55 F + - + - - + - - - - + - Ch.c MC OC 75 - - NO - 3 4 6 ACCC NIL 10 11 UR 
9 Dhanalakshmi 16811 36 F + - - - + + - - - - + - Ch.c SC LC 90 - - NO - 2 4 5 CCC NIL 9 10 UR 
10 Lakshmi  16826 48 F + - + - - + - - - - + - Ch.c MC LC 95 - - NO - 3 4 6 CCC NIL 10 11 UR 
11 Asaithambi 18713 33 M  + + + - + - + - - - + - A C MC+TG OC 100 - - NO - 4 5 7 ACCC NIL 13 14 UR 
12 Radhakrishnan 19087 55     M  + - - - - + - - - - + - Ch.c SC LC 90 - - NO - 3 4 5 CCC NIL 9 10 UR 
13 Padmavathi 18296 28 F  + - - - + + + - - - + - Ch.c SC LC 110 - - NO - 3 3 5 CCC NIL 6 7 UR 
14 Kanaga 26675 58 F  + + - - + + - - - - + - A C SC+TG+DGB LC 90 - - NO - 3 3 4 ACCC NIL 6 7 UR 
15 Subramani 25692 50 M + - - - + - + - - - + - Ch.c SC LC 115 - - NO - 4 7 10 CCC BL 16 17 UR 
16 Papa  25198 70 F + + + + + - - - + + + - C+CDL C+CDL+DCBD OC 140 √ √ Ö - 3 5 7 CCC NIL 15 18 UR 
17 Sabetha  24788 66 F + - - - - - + - - - + - Ch.c MC OC 110 - - NO - 3 4 5 CCC NIL 10 11 UR 
18 Fathima 25718 42 F  + + + - - - - - + - + - A C MC OC 80 - - NO - 3 4 6 ACCC NIL 9 10 UR 
19 Gayathri 24085 33 F + - - - - - + - - - + - Ch.c MC OC 100 - - NO - 3 4 5 CCC NIL 9 10 UR 
20 Saminathan 24394 67 M + - + - - - + - - - + - Ch.c SC LC 100 - - NO - 2 3 4 CCC NIL 5 7 UR 
21 Thilagavathy 23786 34 F + - - - - - - - + - + - Ch.c MC OC 85 - - NO - 3 4 6 CCC NIL 8 9 UR 
22 Megala 23334 45 F + + + - - + + - - - + - A C MC+TG OC 120 - - NO - 4 5 7 ACC NIL 9 10 UR 
23 Malar  22285 40 F + - - - + - - - - - + - Ch.c MC LC 90 - - NO - 3 7 8 CCC SSI 12 14 SR 
24 Malliga 23430 34 F + - - - + - - - - - + - Ch.c SC OC 95 - - NO - 3 5 6 CCC NIL 9 10 UR 
25 Gowsar 23208 33 M + - + - - + + - - - + - Ch.c SC LC 90 - - NO - 2 3 4 CCC NIL 5 6 UR 
26 Murugan 2237 40 M  + - + - + - + - - - + - Ch.c MC LC 130 - - NO - 3 4 5 CCC NIL 8 9 UR 
27 Gnanavel 21663 68 M + - - - - - - - - - + - Ch.c MC OC 70 - - NO - 3 3 5 CCC NIL 8 10 UR 
28 Shanthi 21538 54 F + - + + - - - - - + + - C+CDL MC+CDL+DCBD LC 80 √ - NO - 2 4 4 CCC NIL 10 12 UR 
29 Sasikala 20347 32 F + - + - - - + - - - + - Ch.c MC LC 70 - - NO - 2 3 4 CCC NIL 5 7 UR 
30 Govindammal 20140 60 F + - - - - - - - - - + - Ch.c MC LC 75 - - NO - 2 3 4 CCC NIL 6 7 UR 
31 Shanvasbegam 20534 37 F + + + - - - + - - - + - A C SC+DGB+TG OC 100 - - NO BL 4 8 10 ACC SSI 15 17 UR 
32 Ramya 17615 55 F + - - - - - + - - - + - Ch.c SC OC 70 - - NO - 2 4 6 CCC NIL 10 12 UR 
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33 Kalyani 18439 60 F + - - - - - - - - - + - Ch.c MC LC 60 - - NO - 3 5 6 CCC NIL 10 12 UR 
34 Rani  19686 63 F + - - - + - + - - - + - Ch.c SC LC 90 - - NO SS 3 5 5 CCC NIL 10 12 UR 
35 Yahudhunisha 19321 50 F + - - - + - - - - - + - Ch.c MC LC 65 - - NO - 2 4 5 CCC NIL 9 10 UR 
36 Venkatraman 18524 50  M  + - - - - - - - - - + - Ch.c MC LC 110 - - NO SS 2 3 4 CCC NIL 7 8 UR 
37 Thenmozhi 18974 40 F  + - - - - - + - - - + - Ch.c MC LC 100 - - NO - 2 3 4 CCC NIL 6 7 UR 
38 Kannan 18951 45 M  + - + - - + - - - - + - Ch.c MC LC 90 - - NO - 3 5 7 CCC NIL 11 12 UR 
39 Lakshmi  17592 36 F + - - - - - + + - - + - Ch.c MC LC 80 - - NO - 3 4 6 CCC NIL 10 11 UR 
40 Murugan 17395 47 M  + - + - - + - - - - + - Ch.c MC OC 75 - - NO - 3 5 7 CCC NIL 10 12 UR 
41 Muthulakshmi 18158 51 F  - - - - + - + - - - + - Ch.c MC LC 70 - - NO - 2 3 4 CCC NIL 5 7 UR 
42 Mamula 17201 39 F  + + - - + + - - + - + - A C MC+TG OC 130 - - NO - 3 7 10 ACCC BL 16 17 UR 
43 Mani  15137 63 M  + + + - - + - - - - + - A C MC LC 70 - - NO BL 3 5 5 ACCC NIL 7 9 UR 
44 Kandhasamy 12468 55 M  + - - - + - + - - - + - Ch.c MC LC 60 - - NO - 2 3 4 CCC NIL 6 7 UR 
45 Rajendran 14875 53 M + + + - - - - - - - + - A C SC+TG+DGB LC 80 - - NO - 3 4 5 ACC NIL 7 8 UR 
46 Lilly  14632 43 F + - + - - - + - - - + - Ch.c SC+DGB LC 75 - - NO - 2 3 4 CCC NIL 7 8 URL 
47 Kanniyammal 10619 58 F + - - - - + + - - - + - Ch.c MC LC 80 - - NO - 1 3 3 CCC NIL 6 7 UR 
48 Murugaiyan 13801 55 M + + + - + - - - + - + +      AC SC+TG OC 120 - - NO - 3 7 10 ACCC BL 16 18 SR 
49 Durai Raj 14944 58 M  + - + - - - + - - - + - Ch.c MC LC 100 - - NO - 2 4 5 CCC NIL 6 7 UR 
50 Chitra 194675 42 F + + - - + + - - - - + - Ch.c SC LC 110 - - NO - 3 8 12 CCC BL 15 16 SR 
51 Meshak 13690 28 M  + + - - + + + - - - + - AC MC+TG OC 120 - - NO - 5 6 7 CCC NIL 8 14 UR 
52 Raja  17301 48 M  + - -     -     +      + - - - - - - Symb C MC LC 90 - - NO - 4 4 3 CCC NIL 4 8 UR 
53 Ranjith 18249 64 M  + - - - + - - - - - - - Ch c SC LC 100 - - NO - 4 4 4 CCC NIL 6 10 UR 
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PATIENT CONSENT FORM 
 
Study detail: 
“A  clinical study and management of 
cholelithiasis” 
 
 
Study centre : GOVT  ROYAPETTAH HOSPITAL, CHENNAI 
 
Patients Name:  
 
Patients Age : 
 
Identification 
 
Number  : 
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Patient may check ( ) 
these boxes 
 
 
I confirm that I have understood the purpose of procedure 
for the above study. I had the opportunity to ask question 
and all my questions and doubts have been answered to my 
complete satisfaction.  
 
I understand that my participation in the study is voluntary 
and that I am free to withdraw at any time without giving 
reason, without my legal rights being affected. 
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I understand that sponsor of the clinical study, others working 
on the sponsor‘s behalf, the ethical committee and the 
regulatory authorities will not need my permission to look at 
my health records, both in respect of current study and any 
further research that may be conducted in relation to it, even if 
I withdraw from the study I agree to this access. However, I 
understand that my identity will not be revealed in any 
information released to third parties or published, unless as 
required under the law. I agree not to restrict the use of any 
data or results that arise from this study. 
 
 
I hereby make known that I have fully understood the use of 
above surgical procedure, the possible complications arising 
out of its use and the same was clearly explained to me and 
also understand that this technique is a new method of 
treatment of patella fractures and this study is done to know 
the usefulness of the same in management of patella 
fractures 
 
 
I agree to take part in the above study and to comply with the 
instructions given during the study and faithfully cooperate 
with the study team and to immediately inform the study staff 
if I suffer from any deterioration in my health or well-being 
or any unexpected or unusual symptoms. 
 
 
I hereby consent to participate in this study. 
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I hereby give permission to undergo complete clinical 
examination and diagnostic tests including hematological, 
biochemical, radiological tests. 
 
 
Signature/thumb impression: 
 
Patients Name and 
Address: 
 
place 
 
date
 
Signature of 
investigator 
 
 
: 
Study investigator‘s 
Name : 
Place: 
Date: 
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